Leading Justice is a full-service marketing company working with law firms on a cash buy basis to sign up fully-qualified, fraud-free power morcellation cases. Here at Leading Justice, we can custom-tailor your firm’s power morcellation advertising needs and help you sign up cases via internal cash buys. Our clients only pay an agency fee to cover the cost of power morcellation advertising, plus a fee for each case we sign, and any data we generate for your firm belongs to you. We also cross-qualify all of our contacts, which means any data we generate that doesn’t qualify for the target campaign is reviewed to determine whether it is eligible for another type of claim. By using advanced approaches to target contacts specifically related to power morcellators and complications like leiomyosarcoma and uterine cancer, Leading Justice will increase your firm’s power morcellation case load. If you are interested in helping victims of alleged power morcellation side effects, our extensive consumer reach and direct advertising strategies give you the competitive edge and confidence to allocate your full budget and rest easy knowing your money is being spent in the best way possible.
Each and every law firm we work with at Leading Justice plays an integral role in how we classify claims as qualified or not. Our considerable experience working with plaintiff law firms helps us recognize a great case when we see one, but we will also customize our power morcellation case intake specifications to the exact criteria you are seeking. So, if your firm has specific power morcellator qualifying case criteria you would like us to use, we can train our intake specialists to apply these criteria to each email and phone call they receive. By eliminating the middle man, Leading Justice offers clients an opportunity for internal cash buys of power morcellation data with zero chance of fraud.
Power Morcellation and Cancer Litigation
Power morcellators are surgical devices used during hysterectomies and myectomies (uterine fibroid removal procedures) that allow surgeons to cut up the uterus or tumor and remove the tissue through a small incision in the uterus. Many doctors prefer to use power morcellators during these procedures, because they can help reduce recovery time and the risk of surgical complications. Unfortunately, mounting research indicates that using power morcellators during surgery may actually cause previously undetected cancer cells to spread throughout the body, rapidly upstaging the cancer and consequently reducing the chances of long-term survival.
According to statistics, one out of every 350 women who undergo a hysterectomy or myectomy with power morcellation may have an undiagnosed sarcoma, which could result in a later diagnosis of an aggressive type of uterine cancer called leiomyosarcoma (LMS). As more and more women throughout the country who have undergone surgery with power morcellation become aware of the cancer risks allegedly associated with the controversial surgical device, the number of power morcellator cancer suits filed against manufacturers like Ethicon and Smith & Nephew in courts throughout the country is expected to grow significantly.